Skip to main content
Moupali Das, MD, Infectious Disease, Foster City, CA

MoupaliDasMDMPH

Infectious Disease • Foster City, CA

HIV/AIDS Medicine

Executive Director, HIV and Emerging Viral Infections, Gilead Sciences

Join to view full profile

Dr. Das is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Das' full profile

Already have an account?

  • Office

    333 Lakeside Drive
    Foster City, CA 94404
    Phone+1 650-522-4511

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Infectious Disease, 2005 - 2008
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2001 - 2004
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 2001

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2005 - 2025

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The North-South Divide: Substance Use Risk, Care Engagement, and Viral Suppression Among Hospitalized HIV-Infected Patients in 11 U.S. Cities  
    Deborah K McMahon, Moupali Das, Wendy S Armstrong, Gregory M Lucas, Ank Nijhawan, Raul Mandler, Clinical Infectious Diseases

Lectures

  • 7th International Conference on HIV Treatment & Prevention Adherence 
    International Association of Physicians in AIDS Care, Miami Beach, Florida - 6/3/2012

Press Mentions

  • Dr. Moupali Das, MD, MPH — Gilead Sciences — Dedicated to Ending the HIV Epidemic
    Dr. Moupali Das, MD, MPH — Gilead Sciences — Dedicated to Ending the HIV EpidemicMarch 7th, 2023
  • HIV Capsid Inhibitor Offers New Option for People with Highly Resistant HIV
    HIV Capsid Inhibitor Offers New Option for People with Highly Resistant HIVMarch 10th, 2021
  • Weight Gain While on ART: Demographic, HIV and Treatment-Related Factors
    Weight Gain While on ART: Demographic, HIV and Treatment-Related FactorsOctober 29th, 2019
  • Join now to see all

Dr. Moupali Das, Dr. Moupali Das, MD, Dr. M Das